Bottom line
What is LHCCX's expense ratio?
LHCCX's expense ratio is 1.78%, or about $178 a year on every $10,000 invested. That is more expensive than 89% of health care sector funds we track (median 0.96%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Feb 25, 2026
LHCCX fee table
| Net expense ratio | 1.78% |
|---|---|
| Gross expense ratio | 4.23% |
| Management fee | 0.62% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 2.61% |
| Fee waiver / reimbursement | -2.45% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Feb 25, 2026
What LHCCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| LHCCX | $281 | $1,061 | $1,954 | $4,090 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.78% expense ratio costs roughly $92,100 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).